High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients

Clinical Cancer Research

Volumn 8, Issue 5, 2002, Pages 1167-1171

  Miyoshi, Yasuo ^a   Ando, Akiko ^a   Egawa, Chiyomi ^a   Taguchi, Tetsuya ^a   Tamaki, Yasuhiro ^a   Tamaki, Hiroya ^a   Sugiyama, Haruo ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; WT1 PROTEINS;

EID: 0036091359     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome I1 Wilms' tumor locus
2. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
3. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome
4. Zinc finger point mutations within the WT1 gene in Wilms tumor patients
5. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor
6. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WTI
7. Increased expression of the insulin-like growth factor I receptor gene, 1GF1R, in Wilms tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms tumor gene product
8. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1
9. Repression of the transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product
10. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1
11. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
12. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
13. The possible role and application of WT1 in human leukemia
14. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WTI in leukemogenesis
15. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation
16. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
17. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
18. Fifth International Conference on adjuvant therapy of breast cancer
19. Adjuvant therapy of primary breast cancer, 6th International Conference
20. Quantitative analysis of estrogen receptor-α and -β messenger RNA expression in breast carcinoma by real-time polymerase chain reaction
21. Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. Seventh International Conference on adjuvant therapy of primary breast cancer
22. National Institutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer
23. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas
24. Detection of a novel truncated WT1 transcript in human neoplasia
25. Alternative splicing and genomic structure of the Wilms tumor gene WT1